Drug intelligence / Profile preview

ISC-hpNSC

Development stage
Phase 1
Lead developer
International Stem Cell Corporation
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intracranial, Intrathecal, Ophthalmic
01

Overview

ISC-hpNSC is a proprietary cell therapy consisting of human neural stem cells (hNSCs) derived from human parthenogenetic stem cells (hpSCs). Developed by International Stem Cell Corporation (ISCO), this therapeutic candidate is designed for the treatment of Parkinson's disease. The therapy involves the intracranial transplantation of these neural stem cells into the striatum and substantia nigra of the brain. The mechanism of action is intended to provide neurotrophic support to existing neurons and potentially differentiate into functional dopaminergic neurons to replace those lost to the disease. The use of parthenogenetic stem cells, which are derived from unfertilized oocytes, is intended to minimize immune rejection and avoid the ethical concerns associated with embryonic stem cells.

Brand names
ISC-hpNSC
Other names
human parthenogenetic neural stem cellshPNSC

Beyond the preview

Go deeper on ISC-hpNSC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ISC-hpNSC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call